Seroprevalence and risk factors for human T cell lymphotropic virus type 1 and 2 infection in human immunodeficiency virus-infected patients attending AIDS referral center health units in Londrina and other communities in Paraná, Brazil

AIDS Research and Human Retroviruses

Volumn 21, Issue 4, 2005, Pages 256-262

  Morimoto, Helena K ^a   Caterino De Araujo, Adele ^b   Morimoto, Arilson A ^a,c   Reiche, Edna M V ^a   Ueda, Luiz T ^c   Matsuo, Tiemi ^a   Stegmann, Jan W ^c   Reiche, Fernando V ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c Intgd Ctr Infect Dis of Londrina   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; BRAZIL; COMORBIDITY; CONDYLOMA; CONTROLLED STUDY; DEMOGRAPHY; EDUCATION; FEMALE; GONORRHEA; HEALTH CENTER; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING TEST; SEROLOGY; SEROPREVALENCE; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; SOCIOECONOMICS; SYPHILIS; VIRUS DETECTION; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; BRAZIL; DELTARETROVIRUS ANTIBODIES; EDUCATIONAL STATUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS C ANTIBODIES; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; SYPHILIS;

EID: 18244388967     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.256     Document Type: Article

References (51)

1. Blattner W: Retroviruses. In: Viral Infections of Human Epidemiology and Control (Evans AS, ed.). Plenum Medical, New York, 1989, pp. 545-592.
2. Hinuma Y, Komoda H, Chosa T, et al.: Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: A nation-wide seroepidemiologic study. Int J Cancer 1982;29:631-635.
3. Murphy EL, Figueroa JP, Gibbs WN, et al.: Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants. Am J Epidemiol 1991;133:1114-1124.
4. Fleming AF, Maharajan R, Abraham M, et al.: Antibodies to HTLV-I in Nigerian blood donors, their relatives and patients with leukaemias, lymphomas, and other diseases. Int J Cancer 1986;38:809-813.
5. Wiktor SZ, Piot P, Mann JM, et al.: Human T-cell lymphotropic virus type I (HTLV-I) among female prostitutes in Kinshasa, Zaire. J Infect Dis 1990;161:1073-1077.
6. Lillo F, Varnier OE, Sabbatani S, Ferro A, and Mendez P: Detection of HTLV-I and not HTLV-II infection in Guinea Bissau (West Africa). J Acquir Immune Defic Syndr Hum Retrovirol 1991;4:541-542.
7. Ben-Ishai A, Haas M, Triglia D, Lee V, Nahmias J, Bar-Shany S, and Jensen FC: Human T-cell lymphotropic virus type-I antibodies in Falashas and other ethnic groups in Israel. Nature 1985;315:665-666.
8. Yanagihara R, Jenkins CL, Alexander SS, Mora CA, and Garruto RM: Human T lymphotropic virus type I infection in Papua New Guinea: High prevalence among the Hagahai confirmed by Western blot analysis. J Infect Dis 1990;162:649-654.
9. Manns A, Hisada M, and Grenade LL: Human T-lymphotropic virus type I infection. Lancet 1999;353:1951-1958.
10. Hjelle B, Scalf R, and Swenson S: High frequency of human T-cell leukemia-lymphoma virus type II infection in New Mexico blood donors: Determination by sequence-specific oligonucleotide hybridization. Blood 1990;76:450-454.
11. Hjelle B, Zhu SW, Takahashi H, Ijichi S, and Hall WW: Endemic human T-cell leukemia virus type II infection in southwestern U.S. Indians involves two prototypes variants of virus. J Infect Dis 1993;168:737-740.
12. Hjelle B, Khabbaz RF, Conway GA, North C, Green D, and Kaplan JE: Prevalence of human T-cell lymphotropic virus type II in American Indian populations of the southwestern United States. Am J Trop Med Hyg 1994;51:11-15.
13. Levine PH, Jacobson S, Elliot R, et al.: HTLV-II infection in Florida Indians. AIDS Res Hum Retroviruses 1993;9:123-127.
14. Lairmore MD, Jacobson S, Garcia F, et al.: Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci USA 1990;87:8840-8844.
15. Duenas-Barajas E, Bernal JE, Vaught DR, et al.: Coexistence of human T-lymphotropic virus types I and II among the Wuyuu Indians from the Guajira region of Colombia. AIDS Res Hum Retroviruses 1992;8:1851-1855.
16. Fujiyama C, Fujiyoshi T, Miura T, et al.: A new endemic focus of human T lymphotropic virus type II carriers among Orinoco natives in Columbia. J Infect Dis 1993;168:1075-1077.
17. Duenas-Barajas E, Bernal JE, Vaught DR, et al.: Human retroviruses in Amerindians of Colombia: High prevalence of human T-cell lymphotropic virus type II infection among the Tunebo Indians. Am J Trop Med Hyg 1993;49:657-663.
18. Biglione M, Gessain A, Quiruelas S, et al.: Endemic HTLV-II infection among Tobas and Matacos Amerindians from north Argentina. J Acquir Immune Defic Syndr Hum Retrovirol 1993;6:631-633.
19. Echeverria de Perez G, Leon-Ponte M, Noya O, Botto C, Gallo D, and Bianco N: First description of endemic HTLV-II infection among Venezuelan Amerindians. J Acquir Immune Defic Syndr Hum Retrovirol 1993;6:1368-1372.
20. Maloney EM, Biggar RJ, Neel JV, et al.: Endemic human T-cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis 1992;166:100-107.
21. Black FL, Biggar RJ, Neel JV, Maloney EM, and Waters DJ: Endemic transmission of HTLV type II among Kayapo Indians. AIDS Res Hum Retroviruses 1994;10:1165-1171.
22. Ishak R, Harrington WJ Jr, Azevedo VN, et al.: Identification of human T cell lymphotropic virus type IIa infection in the Kayapo, an indigenous population of Brazil. AIDS Res Hum Retroviruses 1995;11:813-821.
23. Robert-Guroff M, Weiss SH, Giron JA, et al.: Prevalence of antibodies to HTLV-I, II and III in intravenous drug abusers from an AIDS endemic region. J Am Med Assoc 1986;255:3133-3137.
24. Lee HH, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, and Chen I: High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science 1989;244:471-475.
25. Tedder RS, Shanson DC, Jeffries DJ, et al.: Low prevalence in the UK of HTLV-I an HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS. Lancet 1984;2:125-128.
26. Khabbaz RF, Onorato IM, Cannon RD, et al.: Seroprevalence of HTLV-I and HTLV-II among intravenous drug abusers and person in clinics for sexually transmitted diseases. N Engl J Med 1992;326:375-380.
27. Zella D, Mori L, Sala M, et al.: HTLV-II infection in Italian drug abusers. Lancet 1990;336:575-576.
28. Fukushima Y, Takahashi H, Hall WW, et al.: Extraordinary high rate of HTLV type II seropositivity in intravenous drug abusers in South Vietnam. AIDS Res Hum Retroviruses 1995;11:637-645.
29. Caterino-de-Araujo A, Casseb JSR, Neitzert E, et al.: HTLV-I and HTLV-II infectious among HIV-1 seropositive patients in São Paulo, Brazil. Eur J Epidemiol 1994;10:165-171.
30. Schechter M, Harrinson LH, Halsey NA, Trade G, Santino M, Moulton LH, and Quinn T: Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil: Impact on markers of HIV diseases progression. J Am Med Assoc 1994;271:353-357.
31. Brites C, Harrington W Jr, Pedroso C, Netto EM, and Badaro R: Epidemiological characteristics of HTLV-I and II co-infection in Brazilian subjects infected by HIV-1. Braz J Infect Dis 1997; 1:42-47.
32. Brites C, Alencar R, Gusmão R, et al.: Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 2001;15:2053-2055.
33. Brazilian Ministry of Health: Boletim Epidemiólogico - AIDS, Brasília, 2002, XVI, n. 1, abr./dez.
34. Caterino-de-Araujo A, Favero A, Santos-Fortuna E, Sueliman J, Chieco-Bianchi L, and Calabrò ML: HTLV-I/HTLV-II coinfection in an AIDS patient from São Paulo, Brazil. AIDS Res Hum Retroviruses 2000;16:715-719.
35. Dean AG, Dean JA, Coulombier D, et al.: Epi Info, version 6: A Word-Processing Database and Statistics Program for Public Health on IBM-Compatible Microcomputers. Center for Disease Control and Prevention, Atlanta, GA, 1995.
36. Pierik LT and Murphy EL: The clinical significance of HTLV-I and HTLV-II infection in the AIDS epidemic. AIDS Clin Rev 1991;1:39-57.
37. Gotuzzo E, Escamilla J, Phillips IA, Sanchez J, Wignall FS, and Antigoni J: The impact of human T-lymphotropic virus type I/II infection on the prognosis of sexually acquired cases of acquired immunodeficiency syndrome. Arch Intern Med 1992;152:1429-1432.
38. Galvão-Castro B, Loures L, Rodrigues LGM, et al.: Distribution of human T-lymphotropic virus type I among blood donors: A nationwide Brazilian study. Transfusion 1997;37:242-243.
39. Zanetti AR and Galli CG: Seroprevalence of HTLV-I and HTLV-II. N Engl J Med 1992;326:1783.
40. Caterino-de-Araujo A, Santos-Fortuna E, Meleiro MCZ, et al.: Sensitivity of two enzyme-linked immunosorbent assay tests in relation to Western blot in detecting human T-cell lymphotropic virus types I and II infection among HIV-1 infected patients from São Paulo, Brazil. Diagn Microbiol Infect Dis 1998;30:173-182.
41. Vallinoto ACR, Azevedo VN, Santos DEM, et al.: Serological evidence of HTLV-I and HTLV-II coinfections in HIV-1 positive patients in Belém, State of Pará, Brazil. Mem Inst Oswaldo Cruz 1998;93:407-409.
42. Etzel A, Shibata GY, Rozman M, Jorge MLSG, Damas CD, and Segurado AAC: HTLV-1 and HTLV-2 infections in HIV-infected individuals from Santos, Brazil: Seroprevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol 2001;26:185-190.
43. Muller N, Okayama A, Stuver S, and Tachibana N: Findings from the Miyazaki cohort study. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13(Suppl 1):S2-S7.
44. Larsen O, Andersson S, Silva Z, et al.: Prevalences of HTLV-1 infection and associated risk determinants in an urban population in Guinea-Bissau, West Africa. J Acquir Immune Defic Syndr Hum Retrovirol 2000;25:157-163.
45. Bessinger R, Beilke M, Kissinger P, Jarrott C, and Tabak OF. Retroviral coinfections at a New Orleans HIV outpatient clinic. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:67-71.
46. Morofuji-Hirata M, Kajiyama W, Nakashima K, Noguchi A, Hayashi J, and Kashiwagi S: Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years. Am J Epidemiol 1993;137:43-48.
47. Londrina Prefecture: Plano Municipal de Saúde - Biênio 1998-1999, Londrina, 1999.
48. Pappas G, Queen S, Hadden W, and Fisher G: The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med 1993;329:103-109.
49. Mackenbach JP, Kunst AE, Cavelaars AEJM, Groenhof F, Geurts JJM, and EU Working Group on Socioeconomic Inequalities in Health: Socioeconomic inequalities in morbidity and mortality in Western Europe. Lancet 1997;349:1655-1659.
50. Dhalia C, Barreira D, and Castilho EA: A AIDS no Brasil - Situação atual e tendências. Boletim Epidemiológico AIDS, Brasília, 2000, v. XIII, n. 1., pp. 3-13.
51. Fonseca MGP, Szwarcwald CL, and Bastos FI: Análise sociodemográfica da epidemia de AIDS no Brasil, 1989-1997. Rev Saude Publica 2002;36:678-685.